151 related articles for article (PubMed ID: 37810888)
21. Detailed characterization of metastatic lymph nodes improves the prediction accuracy of currently used risk stratification systems in N1 stage papillary thyroid cancer.
Lee J; Kim CH; Min IK; Jeong S; Kim H; Choi MJ; Kwon HJ; Jung SG; Jo YS
Eur J Endocrinol; 2020 Jul; 183(1):83-93. PubMed ID: 32487777
[TBL] [Abstract][Full Text] [Related]
22. Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma.
Kim HI; Hyeon J; Park SY; Ahn HS; Kim K; Han JM; Bae JC; Shin JH; Kim JS; Kim SW; Chung JH; Kim TH; Oh YL
Thyroid; 2019 Jul; 29(7):963-970. PubMed ID: 31025609
[No Abstract] [Full Text] [Related]
23. [Establishment and validation of a nomogram model for evaluating the metastasis of lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma].
Wang ZY; Chang QG; Guo HH; Du X; Liu YH; Yin DT
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(28):2175-2182. PubMed ID: 37482730
[No Abstract] [Full Text] [Related]
24. A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto's thyroiditis to predict central lymph node metastasis.
Zhao W; He L; Zhu J; Su A
Clin Endocrinol (Oxf); 2021 Feb; 94(2):310-321. PubMed ID: 32984984
[TBL] [Abstract][Full Text] [Related]
25. Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma.
Lu W; Zhong L; Dong D; Fang M; Dai Q; Leng S; Zhang L; Sun W; Tian J; Zheng J; Jin Y
Eur J Radiol; 2019 Sep; 118():231-238. PubMed ID: 31439247
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a dynamic nomogram based on conventional ultrasound and contrast-enhanced ultrasound for stratifying the risk of central lymph node metastasis in papillary thyroid carcinoma preoperatively.
Chen Q; Liu Y; Liu J; Su Y; Qian L; Hu X
Front Endocrinol (Lausanne); 2023; 14():1186381. PubMed ID: 37409231
[TBL] [Abstract][Full Text] [Related]
27. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
[TBL] [Abstract][Full Text] [Related]
28. Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer.
Hei H; Gong W; Zheng C; Zhou B; Qin J
Endocrine; 2022 Jun; 77(1):73-79. PubMed ID: 35389141
[TBL] [Abstract][Full Text] [Related]
29. Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.
Guo P; Wang X; Xia L; Shawureding N; Hu Z
Cancer Med; 2023 Apr; 12(7):7868-7876. PubMed ID: 36560883
[TBL] [Abstract][Full Text] [Related]
30. Nomogram for preoperative estimation risk of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a multicenter study.
Zhu J; Chang L; Li D; Yue B; Wei X; Li D; Wei X
Cancer Imaging; 2023 Jun; 23(1):55. PubMed ID: 37264400
[TBL] [Abstract][Full Text] [Related]
31. Extranodal Extension Is an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score Matching Analysis.
Zhou TH; Lin B; Wu F; Lu KN; Mao LL; Zhao LQ; Jiang KC; Zhang Y; Zheng WJ; Luo DC
Front Endocrinol (Lausanne); 2021; 12():759049. PubMed ID: 34803921
[TBL] [Abstract][Full Text] [Related]
32. Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.
Zhao Y; Shi W; Dong F; Wang X; Lu C; Liu C
Front Endocrinol (Lausanne); 2022; 13():1098204. PubMed ID: 36733797
[TBL] [Abstract][Full Text] [Related]
33. [Establishment of model to predict lateral neck recurrence of central lymph node metastasis in papillary thyroid carcinoma].
Xu SY; Ren ZF; Liu J; Huang H; Zhang ZM; Liu SY; Wang XL; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):775-780. PubMed ID: 34289572
[No Abstract] [Full Text] [Related]
34. Clinical and sonographic features for the preoperative prediction of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma.
Zou M; Wang YH; Dong YF; Lai XJ; Li JC
J Endocrinol Invest; 2020 Oct; 43(10):1511-1517. PubMed ID: 32253729
[TBL] [Abstract][Full Text] [Related]
35. An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study.
Chang L; Zhang Y; Zhu J; Hu L; Wang X; Zhang H; Gu Q; Chen X; Zhang S; Gao M; Wei X
Front Endocrinol (Lausanne); 2023; 14():964074. PubMed ID: 36896175
[TBL] [Abstract][Full Text] [Related]
36. Lymph node ratio predicts recurrence in papillary thyroid cancer.
Schneider DF; Mazeh H; Chen H; Sippel RS
Oncologist; 2013; 18(2):157-62. PubMed ID: 23345543
[TBL] [Abstract][Full Text] [Related]
37. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.
Kang JG; Choi JE; Kang SH
World J Surg Oncol; 2022 Sep; 20(1):327. PubMed ID: 36180912
[TBL] [Abstract][Full Text] [Related]
39. Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinoma.
Hei H; Song Y; Qin J
Eur J Surg Oncol; 2019 Jun; 45(6):1039-1045. PubMed ID: 30824213
[TBL] [Abstract][Full Text] [Related]
40. Treatment strategies and predicting lymph node metastasis in elderly patients with papillary thyroid microcarcinoma.
Li W; Tang Y; Li J; Han W; Wang D; Wang Y
Medicine (Baltimore); 2021 May; 100(18):e25811. PubMed ID: 33950985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
